Last $29.48 USD
Change Today +0.61 / 2.11%
Volume 382.0K
EBS On Other Exchanges
Symbol
Exchange
Berlin
New York
As of 8:04 PM 03/4/15 All times are local (Market data is delayed by at least 15 minutes).

emergent biosolutions inc (EBS) Key Developments

Emergent BioSolutions Plans to Expand in Baltimore

Emergent BioSolutions announced that it plans to break ground on an expansion at one of its two Baltimore locations in the next six months. The addition, expected to cost more than $60 million, would roughly double the company's current space on Lombard Street, where it purchased a 58,000-square-foot multi-use manufacturing building in 2009. The company expects to add about 158 jobs at the site over the next four years.

Emergent BioSolutions, Inc. Appoints Jerome Hauer as Class III Director

On January 22, 2015, the Board of Directors of Emergent BioSolutions Inc. approved an increase in the size of the Board from 9 to 10 directors and appointed Jerome Hauer as a Class III director of the company, with an initial term expiring at the 2015 annual meeting of stockholders.

Emergent BioSolutions, Inc.v Provides Earnings Guidance for the Year 2014; Provides Earnings Guidance for the First Quarter and Full Year of 2015

Emergent BioSolutions, Inc. provided earnings guidance for the year 2014. Net income on an adjusted basis is expected to range $53 million to $55 million, or $1.42 to $1.47 per basic share, on total revenues of $445 million to $450 million. The firm estimates it will have approximately $280 million in cash and cash equivalents at year-end 2014. The company is aiming for first quarter of 2015 non-GAAP adjusted net income of $60 million to $70 million on total revenues of $90 million to $105 million. For 2015, the company is targeting revenue in the range of $510 to $540 million. Adjusted net income is seen at $60 million to $70 million. GAAP net income expected to be in the range of $50 million to $60 million.

Emergent BioSolutions, Inc. Presents at Cowen and Company 35th Annual Healthcare Conference, Mar-02-2015 02:10 PM

Emergent BioSolutions, Inc. Presents at Cowen and Company 35th Annual Healthcare Conference, Mar-02-2015 02:10 PM. Venue: The Boston Marriott Copley Place, Boston, Massachusetts, United States.

Emergent BioSolutions, Inc. Presents at Noble Financial Capital Markets Eleventh Annual Investor Conference, Jan-20-2015 03:00 PM

Emergent BioSolutions, Inc. Presents at Noble Financial Capital Markets Eleventh Annual Investor Conference, Jan-20-2015 03:00 PM. Venue: Club Med, Sandpiper Bay, Florida, United States.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EBS:US $29.48 USD +0.61

EBS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Albany Molecular Research Inc $17.20 USD +0.01
Bavarian Nordic A/S kr316.50 DKK +30.50
Depomed Inc $23.65 USD +0.66
View Industry Companies
 

Industry Analysis

EBS

Industry Average

Valuation EBS Industry Range
Price/Earnings 49.9x
Price/Sales 2.7x
Price/Book 2.1x
Price/Cash Flow 49.6x
TEV/Sales 1.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EMERGENT BIOSOLUTIONS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.